Medinol Suit Reveals Alleged Schism Among Boston Scientific Topsiders
This article was originally published in The Gray Sheet
Executive Summary
Pressure is mounting for Boston Scientific to address the apparent rift between its senior-most executives, a division brought to light amidst a growing list of questions relating to the firm's relationship with Israeli stent partner Medinol.